Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis

BMC Complementary and Alternative Medicine

Volumn 8, Issue , 2008, Pages

  Penolazzi, Letizia ^a   Lampronti, Ilaria ^a   Borgatti, Monica ^a   Khan, Mahmud Tareq Hassan ^b,c   Zennaro, Margherita ^a   Piva, Roberta ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; EMBLICA OFFICINALIS EXTRACT; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; DNA BINDING PROTEIN; PLANT EXTRACT;

APOPTOSIS; ARTICLE; BINDING COMPETITION; CELL DIFFERENTIATION; CELL SURVIVAL; COLORIMETRY; CONTROLLED STUDY; DNA SEQUENCE; DRUG SELECTIVITY; DRUG TARGETING; EMBLICA OFFICINALIS; FRUIT; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NICK END LABELING; OSTEOCLAST; PROTEIN EXPRESSION; DOSE RESPONSE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MEDICINAL PLANT; OSTEOLYSIS;

APOPTOSIS; BONE RESORPTION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOHISTOCHEMISTRY; NF-KAPPA B; OSTEOCLASTS; PHYLLANTHUS EMBLICA; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 57049122841     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-8-59     Document Type: Article

References (65)

1. Szekanecz Z Koch AE Macrophages and their products in rheumatoid arthritis Curr Opin Rheumatol 2007, 19:289-95. 10.1097/ BOR.0b013e32805e87ae 17414958
2. Hadjidakis DJ Androulakis II Bone remodeling Ann N Y Acad Sci 2006, 1092:385-96. 10.1196/annals.1365.035 17308163
3. Giuliani N Morandi F Tagliaferri S Rizzoli V Targeting pathways mediating bone disease Curr Pharm Biotechnol 2006, 7:423-9. 10.2174/ 138920106779116955 17168658
4. Blair HC Zaidi M Osteoclastic differentiation and function regulated by old and new pathways Rev Endocr Metab Disord 2006, 7:23-32. 10.1007/ s11154-006-9010-4 17115268
5. Ochi S Shinohara M Sato K Gober HJ Koga T Kodama T Takai T Miyasaka N Takayanagi H Pathological role of osteoclast costimulation in arthritis-induced bone loss Proc Natl Acad Sci USA 2007, 104:11394-11399. 2040909 17592115 10.1073/pnas.0701971104
6. Schett G Cells of the synovium in rheumatoid arthritis. Osteoclasts Arthritis Res Ther 2007, 9:203. 1860063 17316459 10.1186/ar2110
7. Haynes DR Emerging and future therapies for the treatment of bone loss associated with chronic inflammation Inflammopharmacology 2006, 14:193-7. 10.1007/s10787-006-0006-1 17093901
8. Tremoulet AH Albani S Novel therapies for rheumatoid arthritis Expert Opin Investig Drugs 2006, 15:1427-41. 10.1517/13543784.15.11.1427 17040201
9. Boyce BF Schwarz EM Xing L Osteoclast precursors: Cytokine-stimulated immunomodulators of inflammatory bone disease Curr Opin Rheumatol 2006, 18:427-32. 10.1097/01.bor.0000231913.32364.32 16763465
10. Sato K Takayanagi H Osteoclasts, rheumatoid arthritis, and osteoimmunology Curr Opin Rheumatol 2006, 18:419-26. 10.1097/ 01.bor.0000231912.24740.a5 16763464
11. Teitelbaum SL Osteoclasts; culprits in inflammatory osteolysis Arthritis Res Ther 2006, 8:201. 1526550 16356195 10.1186/ar1857
12. Kim KW Cho ML Lee SH Oh HJ Kang CM Ju JH Min SY Cho YG Park SH Kim HY Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation Immunol Lett 2007, 110:54-64. 10.1016/j.imlet.2007.03.004 17467812
13. Colucci S Brunetti G Cantatore FP Oranger A Mori G Quarta L Cirulli N Mancini L Corrado A Grassi FR Grano M Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis J Pathol 2007, 212:47-55. 10.1002/path.2153 17370327
14. Tanishima S Kishimoto Y Fukata S Mizumura H Hagino H Teshima R Minodronic acid influences receptor activator of nuclear factor kB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis Mod Rheumatol 2007, 17:198-205. 10.1007/ s10165-007-0566-y 17564774
15. Kitahara K Kawai S Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis Curr Opin Rheumatol 2007, 19:238-45. 10.1097/ BOR.0b013e328099af80 17414949
16. Gillespie MT Impact of cytokines and T lymphocytes upon osteoclast differentiation and function Arthritis Res Ther 2007, 9:103. 1906805 17381830 10.1186/ar2141
17. Suematsu A Tajiri Y Nakashima T Taka J Ochi S Oda H Nakamura K Tanaka S Takayanagi H Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis Mod Rheumatol 2007, 17:17-23. 10.1007/s10165-006-0531-1 17278017
18. Shu G Yamamoto K Nagashima M Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts Mod Rheumatol 2006, 16:343-9. 10.1007/s10165-006-0515-1 17164994
19. Haynes DR Emerging and future therapies for the treatment of bone loss associated with chronic inflammation Inflammopharmacology 2006, 14:193-7. 10.1007/s10787-006-0006-1 17093901
20. Verdrengh M Carlsten H Ohlsson C Tarkowski A Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis J Orthop Res 2007, 25:304-10. 10.1002/jor.20317 17089391
21. Croom KF Scott LJ Intravenous ibandronate: In the treatment of osteoporosis Drugs 2006, 66:1593-601. 10.2165/00003495-200666120-00005 16956306
22. Chapurlat RD Delmas PD Drug insight: Bisphosphonates for postmenopausal osteoporosis Nat Clin Pract Endocrinol Metab 2006, 2:211-9. 10.1038/ ncpendmet0121 16932286
23. Manette C Collette J Sarlet N Tancredi A Zegels B Reginster JY Comprehensive therapy in osteoporosis using a single drug: From ADFR to strontium ranelate Curr Med Chem 2006, 13:1585-90. 10.2174/ 092986706777442057 16787205
24. Cicek M Oursler MJ Breast cancer bone metastasis and current small therapeutics Cancer Metastasis Rev 2006, 25:635-44. 10.1007/ s10555-006-9035-x 17160709
25. Lipton A Future treatment of bone metastases Clin Cancer Res 2006, 12(20 Pt 2):6305s-6308s. 10.1158/1078-0432.CCR-06-1157 17062719
26. Bagi CM Targeting of therapeutic agents to bone to treat metastatic cancer Adv Drug Deliv Rev 2005, 57:995-1010. 10.1016/j.addr.2004.12.014 15876400
27. Kanakis I Kousidou OCh Karamanos NK In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease In Vivo 2005, 19:311-8. 15796191
28. Putnam SE Scutt AM Bicknell K Priestley CM Williamson EM Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health Phytother Res 2007, 21:99-112. 10.1002/ ptr.2030 17106868
29. New SA Intake of fruit and vegetables: Implications for bone health Proc Nutr Soc 2003, 62:889-99. 15018489
30. Hidaka S Okamoto Y Yamada Y Kon Y Kimura TA Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats Phytother Res 1999, 13:14-9. 10.1002/ (SICI)1099-1573(199902)13:1<14::AID-PTR375>3.0.CO;2-V 10189944
31. Funk JL Oyarzo JN Frye JB Chen G Lantz RC Jolad SD Solyom AM Timmermann BN Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis J Nat Prod 2006, 69:351-5. 2533857 16562833 10.1021/ np050327j
32. Ramprasath VR Shanthi P Sachdanandam P Curative effect of Semecarpus anacardium Linn. nut milk extract against adjuvant arthritis - with special reference to bone metabolism Chem Biol Interact 2006, 160:183-92. 10.1016/j.cbi.2005.11.009 16513099
33. Sohail MT Chaudhry MI Usman MK Mian T Ishaq MN Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders Phytother Res 2005, 19:365-8. 10.1002/ptr.1680 16041739
34. Yin J Tezuka Y Kouda K Le Tran Q Miyahara T Chen Y Kadota S Antiosteporotic activity of the water extract of Dioscorea spongiosa Biol Pharm Bull 2004, 27:583-586. 10.1248/bpb.27.583 15056872
35. Wang D Li F Jiang Z Osteoblastic proliferation stimulating activity of Psoralea corylifollia extracts and two of its flavonoids Planta Med 2001, 67:748-749. 11731919
36. Meng F Xiong Z Sun Y Li F Coumarins from Cidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells Pharmazie 2004, 59:643-645. 15378857
37. Anila L Vijayalakshmi NR Flavonoids from Emblica officinalis and Mangifera indica, effectiveness for dyslipidemia J Ethnopharmacol 2002, 79:81-87. 10.1016/S0378-8741(01)00361-0 11744299
38. Thakur CP Mandal K Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits Indian J Med Res 1984, 79:142-146.
39. Bhattacharya A Kumar M Ghosal S Bhattacharya SK Effect of bioactive tannoid principles of Emblica officinalis on iron-indued hepatic toxicity in rats Phytomedicine 2000, 7:173-175. 10839222
40. Ahmad I Mehmood Z Mohammad F Screening of some Indian medicinal plants for their antimicrobial properties J Ethnopharmacol 1998, 62:183-93. 10.1016/S0378-8741(98)00055-5 9741890
41. Asmawi MZ Kankaanranta H Moilanen E Vapaatalo H Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts J Pharm Pharmacol 1993, 45:581-584. 7689650
42. Jeena KJ Kuttan G Kuttan R Antitumor activity of Emblica officinalis J of Ethnoph 2001, 75:65-69. 10.1016/S0378-8741(00)00378-0
43. Sancheti G Jindal A Kumari R Goyal PK Chemopreventive action of Emblica officinalis on skin carcinogenesis in mice Asian Pac J Cancer Prev 2005, 6:197-201. 16101333
44. Sultana S Ahmad S Khan N Jahangir T Effect of Emblica officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats Indian J Exp Biol 2005, 43:430-6. 15900908
45. Scartezzini P Antognoni F Raggi MA Poli F Sabbioni C Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn J Ethnopharmacology 2006, 104:113-8. 10.1016/j.jep.2005.08.065
46. Penolazzi L Lambertini E Borgatti M Piva R Cozzani M Giovannini I Naccari R Siciliani G Gambari R Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts Biochem Pharmacol 2003, 66:1189-98. 10.1016/ S0006-2952(03)00470-2 14505798
47. Piva R Penolazzi L Lambertini E Giordano S Gambari R Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha Apoptosis 2005, 10:1079-94. 10.1007/s10495-005-0618-8 16151641
48. Borgatti M Lampronti I Romanelli A Pedone C Saviano M Bianchi N Mischiati C Gambari R Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites J Biol Chem 2003, 278:7500-9. 10.1074/jbc.M206780200 12446679
49. Piva R Penolazzi L Zennaro M Bianchini E Magri E Borgatti M Lampronti I Lambertini E Tavanti E Gambari R Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules Ann N Y Acad Sci 2006, 1091:509-16. 10.1196/annals.1378.092 17341640
50. Park BK Zhang H Zeng Q Dai J Keller ET Giordano T Gu K Shah V Pei L Zarbo RJ McCauley L Shi S Chen S Wang CY NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF Nat Med 2007, 13:62-9. 10.1038/nm1519 17159986
51. Yamashita T Yao Z Li F Zhang Q Badell IR Schwarz EM Takeshita S Wagner EF Noda M Matsuo K Xing L Boyce BF NF-{kappa}B p50 and p52 Regulate Receptor Activator of NF-{kappa}B Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1 J Biol Chem 2007, 282:18245-53. 10.1074/jbc.M610701200 17485464
52. Matsuzaki K Katayama K Takahashi Y Nakamura I Udagawa N Tsurukai T Nishinakamura R Toyama Y Yabe Y Hori M Takahashi N Suda T Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene Endocrinology 1999, 140:925-32. 10.1210/en.140.2.925 9927325
53. Villanova I Townsend PA Uhlmann E Knolle J Peyman A Amling M Baron R Horton MA Teti A Oligodeoxynucleotide targeted to the alphav gene inhibits alphav integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis J Bone Miner Res 1999, 14:1867-79. 10.1359/jbmr.1999.14.11.1867 10571687
54. Khan MTH Lampronti I Martello D Bianchi N Jabbar S Choudhuri SMK Datta BK Gambari R Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica Officinalis: Effects on in vitro cell growth of human tumor cell lines Int J Oncol 2002, 20:187-192.
55. Lampronti I Martello D Bianchi N Borgatti M Lambertini E Piva R Jabbar S Shahabuddin Kabir Choudhuri M Tareq Hassan Khan M Gambari R In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa Phytomedicine 2003, 10:300-308. 10.1078/094471103322004794 12809360
56. Denizot F Lang RJ Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability Immunol Meth 1986, 22:271-277. 10.1016/ 0022-1759(86)90368-6
57. Lampronti I Khan MTH Borgatti M Bianchi N Gambari R Inhibitory effects of Bangladeshi medicinal plant extracts on interaction teween transcription factors and target DNA sequences Evidence-based Complementary and Alternative Medicine 2007.
58. Pritts T Hungness E Wang Q Robb B Hershko D Hasselgren PO Mucosal and enterocyte IL-6 production during sepsis and endotoxemia - role of transcription factors and regulation by the stress response Am J Surg 2002, 183:372-83. 10.1016/S0002-9610(02)00812-7 11975924
59. Domingo-Domenech J Oliva C Rovira A Codony-Servat J Bosch M Filella X Montagut C Tapia M Campas C Dang L Rolfe M Ross JS Gascon P Albanell J Mellado B Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity Clin Cancer Res 2006, 12:5578-86. 10.1158/1078-0432.CCR-05-2767 17000695
60. Ameye LG Chee WS Osteoarthritis and nutrition. From nutraceuticals to functional foods: A systematic review of the scientific evidence Arthritis Res Ther 2006, 8:R127. 1779427 16859534 10.1186/ar2016
61. Idris A Mrak E Greig I Guidobono F Ralston SH van't Hof R ABD56 causes osteoclast apoptosis by inhibiting the NFkappaB and ERK pathways Biochem Biophys Res Commun 2008, 371:94-8. 10.1016/j.bbrc.2008.04.014 18413146
62. Uchiyama S Yamaguchi M Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells J Cell Biochem 2007, 101:529-42. 10.1002/jcb.21208 17295206
63. Do SH Lee JW Jeong WI Chung JY Park SJ Hong IH Jeon SK Lee IS Jeong KS Bone-protecting effect of Rubus coreanus by dual regulation of osteoblasts and osteoclasts Menopause 2008, 15:676-83. 18709701
64. Faloni AP Sasso-Cerri E Katchburian E Cerri PS Decrease in the number and apoptosis of alveolar bone osteoclasts in estrogen-treated rats J Periodontal Res 2007, 42:193-201. 10.1111/j.1600-0765.2006.00932.x 17451538
65. Penolazzi L Magri E Lambertini E Bianchini E Piva R Gambari R "In vivo" local transfection of a cis element decoy mimicking an estrogen receptor alpha gene promoter region induces apoptosis of osteoclasts following application of orthodontic forces to rat teeth Apoptosis 2006, 11:1653-6. 10.1007/s10495-006-8763-2 16738804